CIK 0001348362 · Non-accelerated filer<br>Smaller reporting company
Lexaria Bioscience Corp.
Sign in to watch- Ticker
- LEXX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Aug 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 202000871
- Phone
- 250-765-6424
- Business address
- 100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
- Former names
- Lexaria Corp., LEXARIA CORP.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-25 | TURKEL CATHERINE C. Director | Grant or award · Stock Options | +5,000 | 10,000 | ||
| 2023-02-09 | TURKEL CATHERINE C. Director | Purchase | +1,500 | $2.84 | $4K | 1,500 |
| 2022-10-14 | Downey Gregory Chief Financial Officer | Purchase | +121 | $2.09 | $253 | 1,954 |
| 2022-10-14 | Downey Gregory Chief Financial Officer | Grant or award | +121 | $2.09 | $253 | 1,954 |
| 2022-10-13 | BUNKA CHRISTOPHER Chief Executive Officer | Purchase | +16,600 | $2.10 | $35K | 254,412 |
| 2022-10-13 | BUNKA CHRISTOPHER CEO | Grant or award | +16,600 | $2.10 | $35K | 254,412 |
| 2022-10-12 | BUNKA CHRISTOPHER Chief Executive Officer | Purchase | +21,900 | $1.99 | $44K | 237,812 |
| 2022-10-12 | McKechnie William Edward Director | Grant or award · Stock Options | +18,200 | 30,000 | ||
| 2022-10-12 | REESE ALBERT L JR Director | Grant or award · Stock Options | +3,200 | 10,000 | ||
| 2022-10-12 | TURKEL CATHERINE C. Director | Grant or award · Stock Options | +1,600 | 5,000 | ||
| 2022-10-12 | BUNKA CHRISTOPHER CEO | Grant or award | +21,900 | $1.99 | $44K | 237,812 |
| 2022-10-12 | Baxter Nicholas W Director | Grant or award · Stock Options | +18,200 | 30,000 | ||
| 2022-09-02 | TURKEL CATHERINE C. Director | Grant or award · Stock Options | +3,400 | 3,400 | ||
| 2022-08-29 | Carle Vanessa Secretary | Grant or award · Stock Options | +12,500 | 40,067 | ||
| 2022-08-29 | DOCHERTY JOHN MARTIN President | Grant or award · Stock Options | +30,000 | 94,668 | ||
| 2022-08-29 | BUNKA CHRISTOPHER Chief Executive Officer | Grant or award · Stock Options | +30,000 | 101,001 | ||
| 2022-08-29 | Downey Gregory Chief Financial Officer | Grant or award · Stock Options | +11,000 | 46,000 | ||
| 2022-05-24 | REESE ALBERT L JR Director | Grant or award | +5,000 | $1.96 | $10K | 10,917 |
| 2022-05-20 | REESE ALBERT L JR Director | Grant or award | +1,799 | $2.01 | $4K | 5,917 |
| 2022-05-19 | REESE ALBERT L JR Director | Grant or award | +1,501 | $2.01 | $3K | 4,118 |
Page 3 of 6 · 118 trades